The final, formatted version of the article will be published soon.
MINI REVIEW article
Front. Neural Circuits
Volume 18 - 2024 |
doi: 10.3389/fncir.2024.1523614
This article is part of the Research Topic Inducing Lifelong Plasticity (iPlasticity) by Brain Rejuvenation: Elucidation and Manipulation of Critical Period Mechanisms View all 6 articles
Single-cell synaptome mapping: its technical basis and applications in critical period plasticity research
Provisionally accepted- Niigata University, Niigata, Japan
Our brain adapts to the environment by optimizing its function through experience-dependent cortical plasticity. This plasticity is transiently enhanced during a developmental stage, known as the "critical period", and subsequently maintained at lower levels throughout adulthood. Thus, understanding the mechanism underlying critical period plasticity is crucial for improving brain adaptability across the lifespan. Critical period plasticity relies on activity-dependent circuit remodeling through anatomical and functional changes at individual synapses. However, it remains challenging to identify the molecular signatures of synapses responsible for critical period plasticity and to understand how these plasticity-related synapses are spatiotemporally organized within a neuron. Recent advances in genetic tools and genome editing methodologies have enabled single-cell endogenous protein labeling in the brain, allowing for comprehensive molecular profiling of individual synapses within a neuron, namely "single-cell synaptome mapping." This promising approach can facilitate insights into the spatiotemporal organization of synapses that are sparse yet functionally important within single neurons. In this review, we introduce the basics of single-cell synaptome mapping and discuss its methodologies and applications to investigate the synaptic and cellular mechanisms underlying circuit remodeling during the critical period.
Keywords: endogenous proteins, synapse, synaptome, single cell, critical period plasticity, Intrabody, CRISPR/Cas9, Genome editing
Received: 06 Nov 2024; Accepted: 28 Nov 2024.
Copyright: © 2024 Uchigashima and Mikuni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Motokazu Uchigashima, Niigata University, Niigata, Japan
Takayasu Mikuni, Niigata University, Niigata, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.